Hanna Falk1, Lars-Olof Persson, Helle Wijk. 1. Sahlgrenska Academy at Göteborg University, Institute of Health and Care Sciences, Göteborg, Sweden. gusfalkh@student.gu.se
Abstract
BACKGROUND: The aim of the present study was to evaluate the validity, reliability and responsiveness of a Swedish translation of the Quality of Life in Late-Stage Dementia (QUALID) Scale. METHOD: A total of 169 elderly residents at 19 dementia special care units in eight long-term care facilities in the Gothenburg city region participated in the study. Assessments were made by 107 proxy informants. RESULTS: Results showed satisfactory levels of internal consistency reliability (Cronbach's alpha coefficients 0.74), acceptable inter-rater reliability between informants (0.69), and high test-retest reliability (0.86). As hypothesized, QUALID scores were also associated with those from other quality-of-life (QoL) indices (criterion validity), as well as with use of psychoactive drugs, and with tests of cognitive impairment (clinical validity). The responsiveness of the questionnaire was also acceptable. CONCLUSIONS: As important clinical decisions may derive from perceived QoL effects, it is vital that the QoL data be reliable, valid and sensitive to change. Our evaluations of the psychometric properties of the Swedish QUALID indicate that it satisfactorily meets the need for an instrument to assess QoL in late-stage dementia in Sweden, in a wide range of settings and applications.
BACKGROUND: The aim of the present study was to evaluate the validity, reliability and responsiveness of a Swedish translation of the Quality of Life in Late-Stage Dementia (QUALID) Scale. METHOD: A total of 169 elderly residents at 19 dementia special care units in eight long-term care facilities in the Gothenburg city region participated in the study. Assessments were made by 107 proxy informants. RESULTS: Results showed satisfactory levels of internal consistency reliability (Cronbach's alpha coefficients 0.74), acceptable inter-rater reliability between informants (0.69), and high test-retest reliability (0.86). As hypothesized, QUALID scores were also associated with those from other quality-of-life (QoL) indices (criterion validity), as well as with use of psychoactive drugs, and with tests of cognitive impairment (clinical validity). The responsiveness of the questionnaire was also acceptable. CONCLUSIONS: As important clinical decisions may derive from perceived QoL effects, it is vital that the QoL data be reliable, valid and sensitive to change. Our evaluations of the psychometric properties of the Swedish QUALID indicate that it satisfactorily meets the need for an instrument to assess QoL in late-stage dementia in Sweden, in a wide range of settings and applications.
Authors: Josep Garre-Olmo; Xènia Planas-Pujol; Secundino López-Pousa; Myron F Weiner; Antoni Turon-Estrada; Dolors Juvinyà; David Ballester; Joan Vilalta-Franch Journal: Qual Life Res Date: 2010-02-03 Impact factor: 4.147
Authors: Elizaveta Sopina; Lynn Chenoweth; Tim Luckett; Meera Agar; Georgina M Luscombe; Patricia M Davidson; Constance D Pond; Jane Phillips; Stephen Goodall Journal: Qual Life Res Date: 2018-09-05 Impact factor: 4.147
Authors: Dorota Religa; Seyed-Mohammad Fereshtehnejad; Pavla Cermakova; Ann-Katrin Edlund; Sara Garcia-Ptacek; Nicklas Granqvist; Anne Hallbäck; Kerstin Kåwe; Bahman Farahmand; Lena Kilander; Ulla-Britt Mattsson; Katarina Nägga; Peter Nordström; Helle Wijk; Anders Wimo; Bengt Winblad; Maria Eriksdotter Journal: PLoS One Date: 2015-02-19 Impact factor: 3.240
Authors: Hanneke J A Smaling; Karlijn J Joling; Peter M van de Ven; Judith E Bosmans; Joyce Simard; Ladislav Volicer; Wilco P Achterberg; Anneke L Francke; Jenny T van der Steen Journal: BMJ Open Date: 2018-10-15 Impact factor: 2.692
Authors: Linda Clare; Catherine Quinn; Zoe Hoare; Rhiannon Whitaker; Robert T Woods Journal: Health Qual Life Outcomes Date: 2014-12-09 Impact factor: 3.186